Literature DB >> 24316227

Trk receptors need neutral sphingomyelinase activity to promote cell viability.

Ana Candalija1, Roger Cubí1, Arturo Ortega2, José Aguilera3, Carles Gil4.   

Abstract

Neurotrophins are a group of secreted polypeptides, which comprises Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF). Each neurotrophin can bind specifically to a tyrosine kinase Trk receptor (TrkA, TrkB or TrkC), while all of the neurotrophins can bind, with similar affinity, to the p75 neurotrophin receptor (p75(NTR)). Experiments on cell viability promotion by BDNF in granule neurons or by NGF in PC12 cells show that neurotrophin-exerted cell viability is neutral sphingomyelinase (nSMase)-dependent, since GW4869 or siRNA knockdown abrogates the protective effects, as well as neurotrophin-induced Akt phosphorylation. Finally, the assessment of nSMase activity promotion drives to the conclusion that neurotrophins can promote cell viability through Trk receptors in a manner depending on basal nSMase but not through SMase activity enhancement.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; BDNF; Brain-Derived Neurotrophic Factor; CGN; Cer; Ceramide; Granule neuron; MTT; NGF; NT; Nerve Growth Factor; Neurotrophin; PC12; Phosphorylation; SM; SphK; Sphingomyelinase; ceramide; cultured granule neurons; nSMase; neurotrophins; neutral sphingomyelinase; sphingomyelin; sphingosine kinase

Mesh:

Substances:

Year:  2013        PMID: 24316227     DOI: 10.1016/j.febslet.2013.11.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Alcohol Increases Exosome Release from Microglia to Promote Complement C1q-Induced Cellular Death of Proopiomelanocortin Neurons in the Hypothalamus in a Rat Model of Fetal Alcohol Spectrum Disorders.

Authors:  Sayani Mukherjee; Miguel A Cabrera; Nadka I Boyadjieva; Gregory Berger; Bénédicte Rousseau; Dipak K Sarkar
Journal:  J Neurosci       Date:  2020-09-04       Impact factor: 6.167

2.  Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception.

Authors:  Kijung Sung; Luiz F Ferrari; Wanlin Yang; ChiHye Chung; Xiaobei Zhao; Yingli Gu; Suzhen Lin; Kai Zhang; Bianxiao Cui; Matthew L Pearn; Michael T Maloney; William C Mobley; Jon D Levine; Chengbiao Wu
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

Review 3.  Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.

Authors:  Achraf A Shamseddine; Michael V Airola; Yusuf A Hannun
Journal:  Adv Biol Regul       Date:  2014-10-27

4.  Identifying rare variants for genetic risk through a combined pedigree and phenotype approach: application to suicide and asthma.

Authors:  T M Darlington; R Pimentel; K Smith; A V Bakian; L Jerominski; J Cardon; N J Camp; W B Callor; T Grey; M Singleton; M Yandell; P F Renshaw; D A Yurgelun-Todd; D Gray; H Coon
Journal:  Transl Psychiatry       Date:  2014-10-21       Impact factor: 6.222

5.  Effect of Sphingosine-1-Phosphate on Intracellular Free Ca²⁺ in Cat Esophageal Smooth Muscle Cells.

Authors:  Dong Kyu Lee; Young Sil Min; Seong Su Yoo; Hyun Sub Shim; Sun Young Park; Uy Dong Sohn
Journal:  Biomol Ther (Seoul)       Date:  2018-11-01       Impact factor: 4.634

Review 6.  Membrane lipid raft homeostasis is directly linked to neurodegeneration.

Authors:  Tobias Moll; Jack N G Marshall; Nikita Soni; Sai Zhang; Johnathan Cooper-Knock; Pamela J Shaw
Journal:  Essays Biochem       Date:  2021-12-22       Impact factor: 8.000

7.  Interaction between a Novel Oligopeptide Fragment of the Human Neurotrophin Receptor TrkB Ectodomain D5 and the C-Terminal Fragment of Tetanus Neurotoxin.

Authors:  Ana Candalija; Thomas Scior; Hans-Richard Rackwitz; Jordan E Ruiz-Castelan; Ygnacio Martinez-Laguna; José Aguilera
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.